Wireless Power Transfer for Glioblastoma Photodynamic Therapy

Glioblastoma multiforme, the most common and aggressive type of brain cancer, has a dismal prognosis due to inevitable tumor recurrence after maximum treatment with surgery, radiotherapy, and chemotherapy. Recent advances in miniaturized, implantable wireless light delivery devices have demonstrated the potential of chronic treatment of subcutaneous tumors using photodynamic therapy - the selective activation of light-sensitive drugs (photosensitizers) with light to destroy cancer cells. Here we describe the design of a conformal wireless light-emitting mesh (1 cm diameter) to extend this treatment modality to the cortical surface of the brain. The device is wirelessly powered to enable noninvasive activation of intravenously-delivered photosensitizers for chronic treatment, and integrates multiple light-emitting diodes to illuminate large areas. We demonstrate implantation feasibility in rat brain and a light dosimetry control using a harmonic feedback technique. Deploying this device in vivo in combination with selective photosensitizer uptake may enable prolonged suppression of tumor recurrence and increased survival time.

[1]  François Guillemin,et al.  Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies. , 2014, Cancer treatment reviews.

[2]  J. H. Kinsey,et al.  Thermal considerations in murine tumor killing using hematoporphyrin derivative phototherapy. , 1983, Cancer research.

[3]  Lothar Lilge,et al.  Photodynamic therapy in the treatment of intracranial gliomas: A review of current practice and considerations for future clinical directions , 2015 .

[4]  Zhigang Chen,et al.  Near‐Infrared‐Light Activatable Nanoparticles for Deep‐Tissue‐Penetrating Wireless Optogenetics , 2019, Advanced healthcare materials.

[5]  Pui Mun Lee,et al.  Control of wireless power transfer to a bioelectronic device by harmonic feedback , 2018, AIP Advances.

[6]  Claudio H. Sibata,et al.  Oncologic photodynamic therapy photosensitizers: a clinical review. , 2010, Photodiagnosis and photodynamic therapy.

[7]  Youngsik Lee,et al.  Wireless metronomic photodynamic therapy , 2019, Nature Biomedical Engineering.

[8]  M. Sam Eljamel,et al.  ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.

[9]  Thomas S. Mang,et al.  Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? , 2015, Photodiagnosis and photodynamic therapy.

[10]  Hizuru Amano,et al.  Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy , 2018, Nature Biomedical Engineering.

[11]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[12]  C. Mosse,et al.  How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus , 2008, Lasers in Medical Science.

[13]  B. Ziaie,et al.  An Implantable Ultrasonically-Powered Micro-Light-Source (µLight) for Photodynamic Therapy , 2019, Scientific Reports.

[14]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[15]  John S. Ho,et al.  In vivo wireless photonic photodynamic therapy , 2018, Proceedings of the National Academy of Sciences.